Full-Time

Clinical Agent Lead

Product

Updated on 9/10/2026

Trovo Health

Trovo Health

AI-powered virtual assistants for healthcare practices

Compensation Overview

$175k - $250k/yr

+ Equity

New York, NY, USA

Hybrid

Three or more days in the office per week required.

Category
Product (1)
Required Skills
LLM
Product Management

Get referred to Trovo Health

See people who can refer or advise you

Requirements
  • At least 3 years of significant experience owning complex products or operational systems in a fast-moving environment.
  • Technical fluency with software, including shipping code, AI systems, integrations, and implementation tradeoffs.
  • Deep healthcare knowledge and sound instincts for clinical and operational workflows.
  • Ability to work independently on difficult problems with little oversight.
  • Ability to test assumptions, move quickly, and deliver useful work to users.
  • Strong written communication and judgment under ambiguity.
  • Comfort working directly with senior clients and cross-functional teams.
  • Experience using AI effectively and curiosity about how agents can responsibly transform clinical operations.
  • Willingness to work in the New York City office at least three days per week.
Responsibilities
  • Own related clinical agents from concept through deployment, iteration, and expansion.
  • Work directly with clients to understand workflows, constraints, and outcomes, and translate those into agent capabilities.
  • Turn complex clinical and operational problems into clear requirements, workflow designs, prototypes, and real-world solutions.
  • Partner with engineering and contribute directly to implementation, including writing or reviewing pull requests when it helps the team move faster.
  • Partner with commercial and client-facing teams to scope, refine, and support go-to-market strategy for new agents, translating customer and market needs into product requirements and launch plans.
  • Establish how agents are evaluated, monitor performance and failure modes, and drive the next iteration.
  • Identify reusable patterns across client needs and turn them into scalable capabilities rather than one-off custom work.
  • Keep Delivery, Engineering, clinical stakeholders, and leadership aligned on what is shipping and what needs to change.
  • Contribute to product and engineering leadership in defining end-to-end product strategy for the business.
Desired Qualifications
  • Deep healthcare knowledge and sound instincts for clinical and operational workflows.

Trovo Health provides AI-powered virtual assistants for medical practices that help clinicians and staff with routine tasks and patient care. The assistants are trained on specialty-specific models and workflows and plug into existing clinical processes without causing disruption. They handle activities such as patient communication, scheduling, triage, and documentation, guided by a multidisciplinary care team. The goal is to improve patient outcomes and operational efficiency by offering specialty-tailored, integrated AI support.

Company Size

N/A

Company Stage

Series A

Total Funding

$60M

Headquarters

New York

Founded

N/A

Get referred to Trovo Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Oak HC/FT led Thesis Care's $45 million Series A on March 25, 2026.
  • Total funding reached $60 million, supporting commercial expansion and broader care-team agents.
  • Unio Health Partners deployment across 52 locations and 165 providers shows specialty-market traction.

What critics are saying

  • Epic, Microsoft Nuance, Abridge, and Innovaccer crowd healthcare AI buying in 2026.
  • Healthcare AI compliance failures trigger HIPAA investigations, contract cancellations, and liability within one incident.
  • If pilots stall after Cottage Health, Thesis Care becomes another thinly differentiated services startup.

What makes Trovo Health unique

  • Thesis Care rebranded from Trovo Health on March 25, 2026 to signal expansion.
  • Its AI care team agents combine software with human clinicians for workflow execution.
  • Cottage Health partnership on August 4, 2026 validates clinical-operations deployment in health systems.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Unlimited Paid Time Off

Flexible Work Hours

Hybrid Work Options

Company Equity

Parental Leave

Company News

Business Wire
May 26th, 2026
Unio Health Partners deploys AI agents across 500,000-patient specialty care network in California

Thesis Care, an AI-powered care team platform, has partnered with Unio Health Partners to deploy AI care team agents across Unio's specialty practices in California. Unio, the state's largest multi-specialty physician services platform, serves over 500,000 patients annually across 52 locations with 165 physicians. The partnership will deploy Thesis agents across workflows including care gap closure, patient engagement and prior authorisations. Thesis combines AI agents with expert clinicians to complete complex clinical work within existing systems, requiring no additional training for staff. Founded in 2024, Thesis is backed by Oak HC/FT, CRV and Black Opal Ventures. Unio provides urology, gastroenterology and radiation oncology care across California.

MobiHealthNews
Mar 27th, 2026
Trovo Health rebrands as Thesis Care, scores $45M and more funding news.

Trovo Health rebrands as Thesis Care, scores $45M and more funding news. AI revenue cycle management platform Adonis raises $40 million and Blossom Health, a telehealth platform for psychiatry, garners $20 million. By Jessica Hagen | March 27, 2026 | 12:51 PM Thesis Care, formerly Trovo Health, has secured $45 million in Series A funding in a round led by Oak HC/FT, bringing its total funding to $60 million. CRV also participated in the round, alongside Black Opal Ventures and other angel investors. Thesis offers AI agents within healthcare to assist with clinical operations and care management. The company will use the funds for commercial expansion, to enhance its technology platform and to expand its care team agents. "2025 was a defining year for Thesis as we moved from design partnerships into a clear commercial trajectory and growing customer base," Dr. Niren Gandra, CEO and cofounder of Thesis Care, said in a statement. "We've proven that we can extend clinical capacity and allow our customers to do more for patients at a scale that has historically been impossible. Now, we're ready to bring that to every healthcare organization that needs it." Adonis, an AI-enabled revenue cycle management platform, has raised $40 million in Series C funding, bringing its total raise to more than $95 million. Quadrille Capital led the round, with participation from existing investors General Catalyst and Bling Capital. The New York-based company offers an AI orchestration platform that monitors and detects revenue cycle issues by analyzing claims, denials and payer behavior. Adonis plans to use the funds to expand its presence with health systems and grow its workforce in New York. It will also accelerate product innovation across its intelligence, AI agents and orchestration platform. "This funding signals that investors are backing solutions that address the structural problems holding RCM teams back, including RCM workforce shortages, denials, and underpayments," Akash Magoon, cofounder and CEO of Adonis, said in a statement. "Our mission has always been to restore sanity to RCM, and this investment allows us to accelerate the technology RCM teams need to solve these challenges autonomously and at scale." Blossom Health, a telehealth platform for psychiatry, announced it raised $20 million in Series A and seed funding. Headline led the Series A round, with participation from new investors Operator Partners and Correlation Ventures and existing investors Village Global and TA Ventures. Several angel investors were involved in the round as well, including the founders of General Catalyst, Flatiron Health, Sword Health, Fay, Elemy, Zip, Blank Street, Assured, Bridge, Birches Health and Enzo Health. Mathias Schilling, cofounder and managing partner of Headline, joined Blossom Health's board of directors. The company helps individuals seeking mental health support connect with a psychiatrist covered by in-network insurance. The New York-based company will drive to contract with national and regional health insurance payers, expand its state coverage, invest in research and development to advance its AI and onboard more providers.

FinancialContent
Mar 25th, 2026
Thesis Care raises $45M Series A to scale AI-powered clinical teams across healthcare

Thesis Care, formerly Trovo Health, has raised $45 million in a Series A round led by Oak HC/FT, with participation from CRV and Black Opal Ventures, bringing total funding to $60 million. The company combines AI agents with expert clinicians to handle complex clinical operations and care management workflows for healthcare organisations. Founded in 2024 by Niren Gandra and Aditya Pandyaram, Thesis's platform uses AI to deliver personalised patient engagement and complete workflow actions whilst integrating human clinical experts when needed. The system requires no additional training for staff and maintains existing workflows. The company's partnerships span thousands of providers, including US Heart & Vascular, Essen Health Care and Allied Digestive Health. The funding will support commercial expansion, platform development and broadening its suite of care team agents.

Business Wire
May 2nd, 2024
Trovo Health Announces $15 Million Seed Funding Round Led by Oak HC/FT

Trovo Health announced today that it is launching with a $15 million fundraise led by Oak HC/FT. Trovo uses an AI-powered platform backed by a multidi

HIT Consultant
May 1st, 2024
Trovo Health Launches with $15M for AI-Powered Intelligent Assistants

- Trovo Health, a groundbreaking healthcare technology company, announced today its official launch and a $15 million Series A funding round led by Oak HC/FT.